Metavant Sciences is a Durham, North Carolina-based biopharmaceutical company dedicated to developing innovative therapies for metabolic disorders.

We focus on addressing the significant public health challenge posed by diseases like diabetes, leveraging cutting-edge research to create new treatment options.

Metavant Sciences distinguishes itself through a commitment to scientific rigor and a targeted approach to metabolic disease research, aiming to deliver impactful solutions for patients and healthcare providers.

Our current pipeline centers around two investigational drugs, representing a significant step forward in combating these complex conditions. We are driven by a mission to improve patient outcomes and contribute to a healthier future.

Investigational Drug 2 | Metavant Sciences

Service description

Metavant Sciences Durham, United States (US)

Price: N/A

Metavant Sciences
Durham, United States (US)